Novel FDA Approvals
| 3 min read
A novel eye drop from LENZ Therapeutics represents the first time the FDA has approved aceclidine, a cholinergic agonist, in any drug.
| 2 min read
Qfitlia, an RNAi therapeutic given every two months, is the first to target the antithrombin protein instead of missing clotting factors in the blood.
| 3 min read
After decades of stalled innovation, a new oral antibiotic could now combat both everyday infections and urgent public health threats.
Page 1 of 1 - 3 Total Items
